Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIPT evaluation of a sodium hyaluronate + dexpanthenol nasal spray for skin irritation and allergy potential
RBR-2bz5dm6Phase 1Not yet recruiting
- Sponsor
- Allergisa
- Start
- Apr 2023
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-blind, single-arm trial of sodium hyaluronate and dexpanthenol in rhinitis, sponsored by Allergisa. Primary endpoints: Skin irritation potential and Allergic sensitization potential. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
sodium hyaluronatedexpanthenol
03
Conditions
rhinitis
Beyond the preview
Go deeper on RBR-2bz5dm6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2bz5dm6.